GMP Manufacturing

Cell Banking

Robust cell banking is essential to ensure consistent, scalable GMP manufacturing of allogeneic cell therapy products or viral gene therapies. We provide comprehensive support across cell bank production, storage, and quality control, helping you establish a strong foundation for your therapy’s success.

Secure Your Starting Materials with Confidence

For allogeneic cell therapies or viral gene therapies, the cell bank is the critical starting material from which all future clinical and commercial batches are derived. Any variability or compliance gaps at this stage can have downstream consequences across the product lifecycle.

We have experience banking a range of cell types including iPSCs, MSCs, and HEK293 cells, enabling us to support diverse therapeutic platforms. Our cell banking services are designed to reduce risk and ensure regulatory readiness from the start. We understand the technical challenges of generating consistent, high-quality banks and support clients in aligning their strategy with regulatory expectations.

Our Approach

We provide GMP-compliant cell banking as a standalone service or as part of your broader clinical manufacturing programme. With four independently serviced Grade C cleanroom modules, we can dedicate a fully segregated space to cell banking activities, ensuring containment and compliance.

Banks are produced using 2D or 3D systems with capacity for up to 250 vials per batch, depending on the cell line. Controlled-rate freezing is followed by long-term storage in monitored ultra-low freezers or vapour-phase nitrogen tanks.

Every project is managed by our GMP quality team with full batch documentation and QP certification. QC testing is performed in-house and via GMP approved and audited contract testing laboratories, tailored to the specific requirements of your cell type and regulatory strategy.

Cell Banking Capabilities

GMP Cell Bank Production

Master and Working Cell Bank manufacturing for allogeneic cell therapies, using client-supplied material.

Dedicated Cleanroom Modules

Segregated Grade C cleanrooms with local grade A, assigned for cell banking, ensuring containment and regulatory compliance.

Flexible Scale and Format

Banking using 2D and 3D systems, with capacity for up to 250 vials per bank depending on cell line characteristics.

Controlled-Rate Freezing and Storage

Validated freezing protocols with secure storage in ultra-low temperature freezers or vapour-phase nitrogen tanks, both fully monitored and alarmed.

Full QC Testing and Documentation

Banks tested in accordance with GMP and client-specific requirements, with full batch records, QA oversight and QP certification.

Standalone or Integrated Service

Available as a dedicated offering or as part of a full clinical manufacturing programme for seamless continuity.

Why Partner with Us?

Specialist Expertise

Our team has extensive experience generating cell banks across a range of allogeneic cell types.

Seamless Transition to GMP Manufacturing

Cell banks are created with long-term scalability and GMP comparability in mind.

End-to-End Collaboration

Our integrated model ensures every step — from banking to batch release — is fully aligned.

Trusted Regulatory Oversight

In-house QPs and QA experts ensure full compliance with MHRA and other regulatory expectations.

Establish Your Therapy’s Foundation with Confidence

We deliver GMP-grade cell banking services tailored to the needs of allogeneic cell therapies. Contact us today to discuss your project.

Request a Proposal

Other GMP Manufacturing

Clinical Manufacturing

For companies in early-phase trials, our GMP clinical manufacturing capabilities provide scalable solutions with a focus on process robustness, regulatory compliance, and seamless technology transfer. Whether manufacturing autologous, allogeneic, or viral vector-based therapies, we offer the expertise and infrastructure to support successful clinical progression.

Commercial Manufacturing

With future-ready capacity and scalable GMP solutions, our commercial manufacturing services support clients moving into late-stage and commercial production. Our 12,000ft² (1,100m²) expansion space is designed to accommodate larger batch production, supporting 500–1000L viral vector processes, RNA, Lipid Nanoparticles (LNPs), and other advanced technologies.

Fill Finish

Our dedicated fill finish module includes Grade C cleanroom space and a closed Grade A isolator system. We support clinical vial and bag filling for viral vectors and allogeneic therapies, offering standalone or integrated fill finish with full QA oversight and sterility assurance.

GMP Quality & Regulatory

Our in-house QPs and regulatory specialists offer proactive quality oversight and GMP support, from documentation and batch release to audit readiness and training. We ensure compliance is embedded at every stage of your manufacturing journey.

Our Facility

Designed with flexibility, scalability, and compliance in mind, our GMP facility supports the full spectrum of cell and gene therapy modalities. Featuring dedicated manufacturing suites, Fill Finish areas, and QC laboratories, the facility ensures an end-to-end manufacturing solution under one roof.